What is the use of transcerebellar diameter (TCD) in obstetric ultrasound?

Use of Transcerebellar Diameter in Obstetric Ultrasound

The transcerebellar diameter (TCD) is primarily used for accurate gestational age estimation in the third trimester and as a marker for detecting fetal anomalies, particularly neurological abnormalities and intrauterine growth restriction (IUGR).

Primary Clinical Applications

1. Gestational Age Estimation in Third Trimester

The TCD provides superior accuracy for dating pregnancies in the third trimester compared to standard biometric parameters. TCD demonstrates the highest correlation with actual gestational age (r = 0.979) and can estimate gestational age within 6 days of near-term pregnancy 1. This is particularly valuable when:

• Last menstrual period is unknown
• No early ultrasound dating is available
• Standard biometric parameters become unreliable (BPD after 32 weeks, HC and FL after 36 weeks, AC after 28 weeks) 1

The cerebellum is minimally affected by external pressures and molding during pregnancy, making it a more stable measurement 2. Recent Bland-Altman analysis confirms TCD has narrower limits of agreement (-3.56 to 2.25 weeks) compared to composite fetal biometry (-4.73 to 2.53 weeks) 3.

2. Detection of Fetal Anomalies

When TCD falls below the 5th percentile, it serves as a critical marker for associated anomalies. The clinical significance is substantial 4:

• 46.4% of fetuses with extremely small TCD (Z score < -2.5) have major malformations, primarily neurological or cardiac anomalies
• 10% have chromosomal anomalies regardless of severity of cerebellar small size
• 22% experience intrauterine or neonatal demise with extremely small TCD

This finding warrants immediate referral for detailed fetal anatomy scan and karyotyping 4.

3. Assessment of Intrauterine Growth Restriction

The TCD/AC (abdominal circumference) ratio is particularly useful for IUGR evaluation:

• Remains constant in normal pregnancies
• Increases in IUGR pregnancies, indicating asymmetric growth restriction 2
• Combined with uterine artery blood flow parameters (PI, RI, S/D), TCD/AC achieves an AUC of 0.820 for FGR prediction 5

Among IUGR fetuses with small TCD, 75-81.8% experience fetal demise or adverse neonatal outcomes 4, making this a critical prognostic indicator.

Clinical Algorithm for TCD Interpretation

When TCD is below 5th percentile:

1. Perform detailed anatomic survey focusing on neurological and cardiac structures
2. Offer fetal karyotyping
3. Assess for IUGR using TCD/AC ratio and uterine artery Doppler
4. Arrange close surveillance with serial ultrasounds
5. Counsel regarding 40-46% risk of major malformations and 10% risk of chromosomal anomalies

For third-trimester dating when LMP unknown:

1. Measure TCD alongside standard biometry
2. Prioritize TCD measurement as it maintains accuracy within ±6 days near term
3. Use TCD when standard parameters show discrepancies >3 weeks

Important Caveats

While the ACR Appropriateness Criteria guidelines 6 establish the framework for second and third trimester screening, they do not specifically address TCD measurement as a routine component. However, the research evidence strongly supports its utility as an adjunct parameter, particularly when standard biometry becomes unreliable or when cerebellar abnormalities are suspected.

The cerebellum's relative sparing in IUGR makes TCD especially valuable in growth-restricted fetuses, where head-sparing physiology can make other cranial measurements misleading 2.